Literature DB >> 3925753

The evaluation of factor VIII antigen by means of a simple slide test.

A Casonato, F Fabris, M Vicariotto, A Girolami.   

Abstract

Factor VIII von Willebrand may be detected by a Ristocetin-dependent platelet agglutination reaction. The authors have measured plasma levels of Factor VIII-related Ristocetin cofactor (VIIIR:RCoF) using formalin-fixed platelets tested by an aggregometric method or by a new, commercially available glass slide test. Plasmas were obtained from patients with von Willebrand's disease and Cushing's syndrome, and from normal controls. Von Willebrand factor (vWf) levels varied between 0-500% of the normal. A good correlation (r = 0.95) was found comparing the results obtained by the two methods over the entire range. If all patients were considered, a satisfactory correlation was obtained between VIIIR:RCoF and VIII-related antigen (VIIIR:Ag), both by the aggregometric method (r = 0.79) and by the glass slide method (r = 0.88). On the contrary, if values below 25% of the normal are taken into account, only a mild correlation was found between VIIIR: RCoF (aggregometric method) and VIIIR:Ag and no correlation between VIIIR:RCoF (glass slide method) and VIIIR:Ag. No correlation, regardless of the method used, was found between VIIIR:RCoF and VIIIR:Ag for values above 120%.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925753     DOI: 10.1093/ajcp/84.1.107

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Increased factor VIII/vWf levels in patients with reduced platelet number.

Authors:  A Casonato; F Fabris; M Boscaro; A Girolami
Journal:  Blut       Date:  1987-05

2.  Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells.

Authors:  A S Asch; B Adelman; M Fujimoto; R L Nachman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors.

Authors:  A Casonato; E Pontara; A Bertomoro; D Dannhauser; S Secchiero; M Zaninotto; A Girolami
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

4.  Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapy.

Authors:  A Doria; A Ghirardello; M Boscaro; M L Viero; E Vaccaro; G M Patrassi; P F Gambari
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

5.  Discrepancies between von Willebrand factor multimeric composition and other tests in some von Willebrand's disease variants.

Authors:  A Casonato; F Fabris; L De Marco; A Girolami
Journal:  Blut       Date:  1987-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.